Article
CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials.
Atherosclerosis - 1 Dec 2009
Hermann M, Hellermann J P, Quitzau K, Hoffmann M M, Gasser T, Meinertz T, Münzel T, Fleming I, Lüscher T F
Abstract excerpt
BACKGROUND: Cytochrome P450 (CYP) is expressed in the human endothelium and metabolizes arachidonic acid into vasoactive epoxyeicosatrienoic and 20-hydroxyeicosatetraenoic acids. CYP enzymes have been linked to hypertension and generation of reactive oxygen species. Thus, we investigated the impact of several CYP polymorphisms on coronary endothelial function in patients with coronary artery disease (CAD)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
